US Patent 7141421 Control of metabolism with human 2-oxoglutarate carrier
Patent 7141421 was granted and assigned to Genentech on November, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+134 characters)
Article
Patent abstract
The present invention is directed to compositions and methods related to the use of human OGC as an uncoupling protein.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07141421 Control of metabolism with human 2-oxoglutarate carrier US Patent 7141421 Control of metabolism with human 2-oxoglutarate carrier
Infobox
Patent Number
0714142100
Patent Number
714142100
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071414210
Date of Patent
November 28, 2006
0Patent Application Number
098882640
Date Filed
June 22, 2001
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071414210
Date of Patent
November 28, 2006
0Patent Application Number
098882640
Date Filed
June 22, 2001
0Official Website
Patent Primary Examiner
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07141421 Control of metabolism with human 2-oxoglutarate carrier
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07141421
Date of patent
November 28, 2006
Patent application number
09888264
Date Filed
June 22, 2001
Patent primary examiner
Find more entities like US Patent 7141421 Control of metabolism with human 2-oxoglutarate carrier
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.